Cassava Sciences: Fine Trading Stock, Terrible Investment

| Stock Market News, Stock Advice & Trading Tips     •     October 11, 2021, 2:11 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SAVA stock has fallen sharply in recent weeks. However, it's still a rather expensive bet on a controversial drug heading into Phase 3…
| Stock Market News, Stock Advice & Trading Tips     •     October 11, 2021, 2:33 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Protagonist Therapeutics (PTGX) stock is rocketing higher on Monday thanks to an update from the FDA concerning rusfertide clinical…

Comments

Popular posts from this blog

3 Retirement Stocks to Make Your Golden Years Gleam

Why Mullen (MULN) Stock Is Shaking Off Tesla’s EV Plunge Today

GMBL Stock Earnings: Esports Entertainment Misses EPS, Misses Revenue for Q3 2024